Ilex paraguariensis has antioxidant potential and attenuates haloperidol-induced orofacial dyskinesia and memory dysfunction in rats

Neurotoxicity Research

Volumn 12, Issue 3, 2007, Pages 171-180

  Colpo, Gabriela ^a   Trevisol, Fabíola ^a   Teixeira, Angélica M ^a   Fachinetto, Roselei ^a   Pereira, Romaiana P ^a   Athayde, Margareth Linde ^a   Rocha, João Batista Teixeira ^a   Burger, Marilise E ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Haloperidol; Ilex paraguariensis; Orofacial dyskinesia; Tardive dyskinesia

Indexed keywords

ANTIOXIDANT; HALOPERIDOL; ILEX PARAGUARIENSIS EXTRACT; IRON; NITROPRUSSIDE SODIUM; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; PLANT MEDICINAL PRODUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; CONTROLLED STUDY; DRUG ISOLATION; IC 50; ILEX PARAGUARIENSIS; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; MASTICATION; MAZE TEST; MEMORY DISORDER; NONHUMAN; OROFACIAL DYSKINESIA; OXIDATIVE STRESS; PLANT LEAF; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; MOTOR DYSFUNCTION; MOVEMENT (PHYSIOLOGY); PHYTOTHERAPY; TIME; WISTAR RAT;

ANIMALIA; ILEX PARAGUARIENSIS; RATTUS;

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; HALOPERIDOL; ILEX PARAGUARIENSIS; MALE; MAZE LEARNING; MEMORY DISORDERS; MOVEMENT; MOVEMENT DISORDERS; PHYTOTHERAPY; PLANT PREPARATIONS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 39749088189     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033914     Document Type: Article

References (87)

1. Abilio VC, CC Araujo, M Bergamo, PR Calvente, V D'Almeida, R Ribeiro and R Frussa-Filho (2003) Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2, 7109-7114.
2. Abilio VC, RH Silva, RC Carvalho, C Grassl, MB Calzavara, S Registro, V D'Almeida, RA Ribeiro and R Frussa-Filho (2004) Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia. Neuropharmacology 47, 263-272.
3. Ames BN, MK Shigenaga and TM Hagen (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad, Sci. USA 90, 7915-7922.
4. Andreassen AO and HA Jorgensen (2000) Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? Neurobiol. 61, 525-41, 2000.
5. Andreassen AO, RJ Ferrante, TO Aamo, MF Beal and HA Jorgensen (2003) Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience 122, 717-725.
6. Anesini C, G Ferraro and R Filip (2006) Peroxidase-like activty of Ilex paraguariensis. Food Chem. 97, 459-464.
7. Athayde ML, GC Coelho and EP Schenkel (2000) Caffeine and theobromine in epicuticular wax of Ilex paraguariensis A. St.-Hil. Phytochemistry 55, 853-857.
8. Baldessarini RJ JO Cole, JM Davis, G Simpson, D Tarsy, G Gardos and SJ Preskorn (1980) Tardive diskinesia: Summary of a task force report of the American Psychiatric Association. Am. J. Psychiatry 137, 1163-1172.
9. Bellé NAV, GD Dalmolin, MA Rubin and JBT Rocha (2004) Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res. 1008, 245-251.
10. Bergamo M, VC Abilio, CMT Queiroz, HN Barbosa-Junior, LRA Abdanur and R Frussa-Filho (1997) Effects of age on a new model of tardive dyskinesia. Neurobiol. Aging 18, 623-629.
11. Bishnoi M, K Chopra and SK Kulkarni (2006) Involvement of adenosinergic receptor system is an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes. Eur. J. Pharmacol. 552, 55-66.
12. Bixby M, L Spieler, T Menini and A Gugliucci (2005) Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: A comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci. 77, 345-358.
13. Burger ME, A Alves, L Callegari, FR Athayde CW Nogueira, G Zeni and JBT Rocha (2003) Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum. Prog. Psychopharmacol. Biol. Psychiatry 27, 135-140.
14. Burger M, R Fachinetto, L Calegari, MW Paixão, AL Braga and JBT Rocha (2004) Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide. Brain Res. Bull. 64, 339-345.
15. Burger ME, R Fachinetto, A Alves, L Callegari and JBT Rocha (2005a) Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats. Brain Res. 1031, 202-210.
16. Burger ME, R Fachinetto G Zeni and JBT Rocha (2005b) Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain. Pharmacol. Biochem. Behav. 81, 608-615.
17. Burger ME, R Fachinetto, C Wagner, J Perottoni, RP Pereira, G Zeni and JBT Rocha (2006) Effects of diphenyl-diselenide on orofacial dyskinesia model in rats. Brain Res. Bull. 70, 165-170.
18. Cabrera J, RJ Reiter, D Tan, W Qi, RM Sainz, JC Mayo, JJ Garcia, SJ Kim and G El-Sokkary (2000) Melatonin reduces oxidative neurotoxicity due to quinolinic acid: In vitro and in vivo findings. Neuropharmacology 39, 507-514.
19. Cadet JL, JB Lohr and DV Jeste (1986) Free radicals and tardive dyskinesia. Trends Neurosci 9, 107-108.
20. Cadet JL, JB Lohr and DV Jest (1987) Tardive dyskinesia and schizophrenic burnout: The possible involvement of cytotoxic free radicals, In: HandbooT of Schizophrenia: the Neurochemistry and Pharmacology of Schizophrenia (Henn FA and LE DeLisi, Eds.) (Elsevier: Amsterdam), pp 425-438.
21. Carini M, RM Facino, G Aldini, M Calloni and L Colombo (1998) Characterization of phenolic antioxidants from mate (Ilex paraguariensis) by liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrum 12, 1813-1819.
22. Casas MF, S Ferre, T Guix and F Jane (1988) Theophylline reverses haloperidol-induced catalepsy in the rat: Possible relevance to the pharmacological treatment of psychosis. Biol. Psychiatry 24, 642-648.
23. Casey DE (1995) Tardive dyskinesia pathophysiology, In: Psychopharmacology: The Fourth Generation of Progress (Bloom FE and DJ Kupfer, Eds.) (Raven Press: New York, NY) pp 1497-1502.
24. Casey DE (2000) Tardive dyskinesia: Pathophysiology and animal models. J. Clin. Psychiatry 61, 5-9.
25. Chandra S and EG Mejia (2004) Polyphenolic compounds, antioxidant capacity, and quinine reductase activity of an aqueous extract of Ardisia compressa in comparison to mate (Ilex paraguariensis) and green (Canelia sinensis) teas. J. Agric. Food Chem. 52, 3583-3589.
26. Clifford MN and JR Ramirez-Martines (1990) Chlorogenic acids and purine alkaloids contents of Mate (Ilex paraguariensis) leaf and beverage. Food Chem. 35, 13-21.
27. Coelho GC, ML Athayde and EP Schenkel (2001) Methylxanthines of Ilex paraguariensis A. St.-Hil. var vestita Loes. and var. paraguariensis. Braz. J. Pharm. Sci. 37, 153-158.
28. Cooke D, WP Steward, AJ Gescher and T Marezylo (2005) Anthocyans from fruits and vegetables-Does bright colour signal cancer chemopreventive activity? Eur. J. Cancer 41, 1931-1940.
29. Coyle JT and P Puttfarcken (1993) Oxidative stress glutamate and neurodegenerative disorders. Science 262, 689-695.
30. Creese I, D Burt and SH Snyder (1976) Dopamine receptor bindings predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481-483.
31. Cruz GL (1982) Dicionário das Plantas Úteis do Brasil, 2nd Ed. (Bertrand Brasil: Rio de Janeiro), 599 pp.
32. Dall'lgna OP, LO Porciúncula, D Souza, RA Cunha and DR Lara (2003) Neuroprotection by caffeine and adenosine A 2A receptor blockade of β-amyloid neurotoxicity. Br. J. Pharmacol. 138, 1207-1209.
33. Dominguez M, A Nieto, JC Marin, AS Keck, E Jeffery and CL Cespedes (2005) Antioxidant activities of extracts from Barkleyanthus salicifolius (Asteraceae) and Penstemon gentianoides (Scrophularlaceae). J. Agric. Food Chem. 53, 5889-5895.
34. Egan ME, J Apud and RJ Wyatt (1997) Treatment of tardive dyskinesia. Schizophr. Bull. 23, 583-609.
35. Elkashef AM and RJ Wyatt (1999) Tardive dyskinesia: Possible involvement of free radicals and treatment with vitamin E. Schizophr. Bull. 25, 731-740.
36. Fachinetto R, ME Burger, C Wagner, DC Wondracek, VB Brito, CW Nogueira, J Ferreira and JBT Rocha (2005) High fat diet increases the incidence of orofacial dyskinesia and oxidative stress in specific brain regions of rats. Pharmacol. Biochem. Behav. 81, 585-592.
37. Faria PR, VC Abilio, C Grassl, CC Chinen, LTR Negrão, JPMV Castro, DF Fukushiro, MSD Rodrigues, PHZ Gomes, S Registro, RC Carvalho, V D'Almeida, RH Silva, RA Ribeiro and R Frussa-Filho (2005) Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: Critical role of striatal catalase activity. Neuropharmacology 48, 993-1001.
38. Filip R, SB Lotito, G Ferraro and CG Fraga (2000) Antioxidant activity of Ilex paraguariensis and related species. Nutr. Res. 20 1437-1446.
39. Filip R, P López, G Giberti, J Coussio and G Ferraro (2001) Phenolic compounds in seven, South American Ilex, species. Fitoterapia 72, 774-778.
40. Ghisleine G, LO Porciúncula, H, Cimarosti, JBT Rocha, CG Salbego and DO Souza (2003) Diphenyl diselenide protects rat hippocampal slices submited to oxygen-glucose deprivation and diminishes inducible nitric oxide synthase immunocontent. Brain Res. 986, 196-199.
41. Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause or consequence? Lancet 344, 721-724.
42. Harman D (1992) Role of free radicals in aging and disease. Ann. NY Acad. Sci. 673, 126-141.
43. Hertog MGL, EJM Feskens, PCH Hollman, MB Katan and D Kroumhout (1993) Dietary antioxidant flavonoids, and risk of coronary heart disease: The zutphen elderly study. Lancet 342, 1007-1011.
44. Hertog MGL, D Kroumhout, C Aravanis, H Blackburn, R Buzina, F Fidanza, S Giampaoli, A Jansen, A Menotti, S Nedeljkovic, M Pekkarinen, B Simic, H Toshima, EJM Feskens, PCH Hollman and MB Katan (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155, 381-386.
45. 3H] raclopride binding to neostriatal homogenates. J. Pharmacol. Exp. Ther. 280, 268-276.
46. Ikeda H, K Adachi, M Hasegawa, M Sato, N Hirose, N Koshikawa and AR Cools (1999) Effects of chronic haloperidol and clozapine on vacuous chewing and dopaminemediated jaw movements in rats: Evaluation of a revised animal model of tardive dyskinesia. J. Neural Transm. 106, 1205-1216.
47. Johnson IT (2004) New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutat. Res. Fundam. Mol. Mech. Mutagen. 551, 9-28.
48. Jovanovic SV, S Steenken, MG Simic and Y Hara (1998) Antioxidant properties of flavonoids: Reduction potentials and electron transfer reactions of flavonoid radicals, In: Flavonoids in Health and Disease (Rice-Evans C and L Packer, Eds.) (Macel Dekker: New York, NY), p 137.
49. Kane JM (1995) Tardive dyskinesia epidemiological and clinical presentation, In: Psychopharmacology: The Fourth generation of Progress (Bloom FE and DJ Kupfer, Eds.) (Raven Press: New York, NY), pp 1485-1495.
50. Kane JM and JM Smith (1982) Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979. Arch. Gen. Psychiatry 39, 473-481.
51. Konitsiotis S, C Tsironis, DN Kiortsis and A Evangelou (2006) Effects of N -methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesia. Psychopharmacology 185, 369-377.
52. Kulkarni SK and PS Naidu (2001) Tardive dyskinesia: An update. Drugs Today 37, 97-119.
53. Lohr JB (1991) Oxygen radicals and neuropsychiatric illnesssome speculations. Arch. Gen. Psychiatry 48, 1097-1106.
54. Lohr JB, R Kuczenski, HS Bracha, M Moir and DV Jeste (2003a) Increased indices of free radical activity in the cerebrospinal fluido of patients with tardive dyskinesia. Biol. Psychiatry 28, 535-539.
55. Lohr JB, R Kuczenski and AB Niculescu (2003b) Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17, 47-62.
56. Mandhane SN, CT Chopde and AK Ghosh (1997) Adenosine A 2 receptors modulate haloperidol-induced catalepsy in rats. Eur. J. Pharmacol. 328, 135-145.
57. Mazzafera P (1994) Caffeine, theobromine and theophylline distribuition in Ilex paraguariensis. Rev. Bras. Fisiol. Veg. 6, 149-151.
58. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60.
59. Naidu PS and SK Kulkarni (2001) Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): Possible involvement of calcium and nitric oxide. Behav. Pharmacol. 12, 209-216.
60. Naidu PS, A Singh and SK Kulkami (2003) Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: Possible mechanisms of action. J. Med. Food. 6, 107-114.
61. Neisewander JL, E Castafieda, DA Davis, HJ Elson and AN Sussman (1996) Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia. Eur. J. Pharmacol. 305, 13-21.
62. Nogueira CW, G Zeni and JBT Rocha (2004) Organoselenium and organotellurium compouds: Toxicology and pharmacology. Chem. Rev. 104, 6255-6285.
63. Ohkawa H, H Ohishi and K Yagi (1979) Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
64. Ploeger GE, BM Spruijt and AR Cools (1992) Effects of haloperidol on the acquisition of a spatial learning task. Physiol. Behav. 52, 979-983.
65. Ploeger GE, BM Spruijt and AR Cools (1994) Spatial localization in the Morris water maze in rats: Acquisition is affected by intra-accumbens injections of the dopaminergic antagonist haloperidol. Behav. Neurosci. 108, 927-934.
66. Polydoro M, N Schröder, MNM Lima, F Caldana, D Laranja, E Bromberg et al. (2004) Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol. Biochem. Behav. 78, 751-758.
67. Queiroz CMT and R Frussa-Filho (1999) Effects of buspirone on an animal model of tardive dyskinesia. Prog. Psychopharmacol. Biol. Psychiatry 23, 1403-1418.
68. Raghavendra V, PS Naidu and SK Kulkarni (2001) Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors. Brain Res. 904, 149-152.
69. Reginatto, FH, ML Athayde, G Gosmann and EP Schenkel (1999) Methylxanthines accumulation in Ilex species caffeine and theobromine in erva-mate (Ilex paraguariensis) and other Ilex species. J. Braz. Chem. Soc. 10, 443-446.
70. Rice-Evans C, NJ Miller and G Paganga (1996) Structureantioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol. Med. 20, 933-956.
71. Rietveld A and S Wiseman (2003) Antioxidant effects of tea: Evidence from human clinical trials. J. Nutr. 133, 3285S-3292S.
72. Rogoza RM, DF Fairfax, P Henry, S N-Marandi, RF Khan, SK Gupta and RK Mishra (2004) Electron spin resonance spectroscopy reveals α-phenyl- N -tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Synapse 54, 156-163.
73. Rosengarten H and D Quatermain (2002) The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three-and eighteenmonth-old rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26, 1047-1054.
74. Rossato JI, G Zeni, CF Mello, ME Rubin and JBT Rocha (2002) Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic-acid administration in the rat. Neurosci. Lett. 318, 137-140.
75. Sachdev P, T Saharov and S Cathcart (1999) The preventative role of antioxidant (selegiline and vitamin E) in a rat model of tardive dyskinesia. Biol. Psychiatry 46, 1672-1681.
76. Santamaría A, R Salvatierra-Sanchez, B Vazquez-Roman, D Santiago-Lopez, J Villeda-Hernandez, S Galavan-Arzates, ME Jimenez-Capdeville and SF Ali (2003) Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J. Neurochem. 86, 479-488.
77. Schenkel EP, JA Montanha and G Gosmann (1996) Triterpene saponins from mate, I. paraguariensis, In: Saponins Used in Food and Agriculture, vol. 405 (Waller GR and K Yamasaki, Eds.), Series Advances in Experimental Medicine and Biology, (Plenum Press. New York, NY), pp 47-56.
78. Schinella GR, G Troiani, V Dávila, PM Buschiazzo and HA Tournier (2000) Antioxidant effects of an aqueous extract of Ilex paraguariensis Biochem. Biophys. Res. Commun. 269, 357-360.
79. Schubert A, FF Zanin, DF Pereira and ML Athayde (2006) Variação anual de metilxantinas totais em amostras de Ilex paraguariensis A. ST. Hil. (erva-mate) em Ijui e Santa Maria, Estado do Rio Grande do Sul. Quimica Nova 29, 1233-1236.
80. Shoham S, H Mazeh, DC Javitt and U Heresco-Levy (2004) Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia. Brain Res. 1004, 142-147.
81. Sharma S, P Paladino, J Gabriele, H Saeedi, P Henry, M Chang, PK Mishra and RL Johnson (2003) Pro-Leuglycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia. Peptides 24, 313-319.
82. Steffen Y, T Schewe and H Sies (2005) Epicatechin protects endothelial cells againt oxidized LDL and naintains NO synthase. Biochem. Biophys. Res. Comun., 331, 1277-1283.
83. Tsai G, DC Goff, RW Change, J Flood L Bair and JT Coyle (1998) Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am. J. Psychiatry 155, 1207-1213.
84. Turrone P, G Remington, S Kapur and JN Nóbrega (2003) Differential effects of within-day continuous vs transient dopamine D-2 receptor occupancy in the development of vacuous chewing movements (VCM) in rats. Neuropsychopharmacology 28, 1433-1439.
85. VanderJagt TJ, R Ghattas, DJ VanderJagt, M Crossey and RH Glew (2002) Comparison of the total antioxidant content of 30 widely used medicinal plants of New Mexico. Life Sci. 70, 1035-1040.
86. Vinson J, Y Dabbagh, MM Serry and J Jang (1995) Plant polyphenols, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease. J. Agric. Food Chem. 43, 2800-2802.
87. Wagner C, R Fachinetto, CL Dalla Corte, VB Brito, D Severo, GO Costa Dias, AF Morel, CW Nogueira and JBT Rocha (2006) Quercitrin, a glycoside form of quercetin, preveats lipid peroxidation in vitro. Brain Res. 1107, 192-198.